Fundraising FoxEdinburgh Molecular Imaging
2 known investors
Find your way into Edinburgh Molecular Imaging
Sign up to see every warm intro you have to Edinburgh Molecular Imaging
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Edinburgh Molecular Imaging team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
University of Edinburgh spin-out clinical-phase biotech developing C-Met molecular targeting technology for cancer radiotherapy and imaging.
Investors · 2
Epidarex Capitallisted by Epidarex CapitalBethesda · $2.5M – $6.3M
How we know: Epidarex Capital's portfolio page · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
Scottish Investment BankreportedGlasgow · $250K – $2M
How we know: funding news · Not right? Tell us
Frequently asked questions
- What does Edinburgh Molecular Imaging do?
- University of Edinburgh spin-out clinical-phase biotech developing C-Met molecular targeting technology for cancer radiotherapy and imaging.
- Who are Edinburgh Molecular Imaging's investors?
- Edinburgh Molecular Imaging's investors include Epidarex Capital, Scottish Investment Bank.